The blood-brain barrier for catecholamines - Revisited

Neurotoxicity Research

Volumn 11, Issue 3-4, 2007, Pages 261-271

  Kostrzewa, Richard M ^a  

^a East Tennessee State University   (United States)

Author keywords

6 Hydroxydopa; 6 Hydroxydopamine; Blood brain barrier; Catecholamine; Metaraminol; Norepinephrine

Indexed keywords

6 HYDROXYDOPA; CARBIDOPA; CATECHOLAMINE; DECARBOXYLASE INHIBITOR; METARAMINOL; NEUROTOXIN; NORADRENALIN; OXIDOPAMINE; TRITIUM; ADRENERGIC RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; FOREBRAIN; MALE; NEOCORTEX; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; RAT; RHOMBENCEPHALON; AGE; ANIMAL; BRAIN; BRAIN LEVEL; DRUG EFFECT; DRUG INTERACTION; GROWTH, DEVELOPMENT AND AGING; HISTOLOGY; METABOLISM; NEWBORN; SPRAGUE DAWLEY RAT;

RATTUS;

ADRENERGIC AGENTS; AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; BLOOD-BRAIN BARRIER; BRAIN; BRAIN CHEMISTRY; CARBIDOPA; CATECHOLAMINES; DOPAMINE AGENTS; DRUG INTERACTIONS; FEMALE; MALE; METARAMINOL; OXIDOPAMINE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 34548450657     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033571     Document Type: Article

References (20)

1. 3-epinephrine and its metabolite metanephrine. J. Pharmacol. Exp. Ther. 127, 251-256.
2. Bartholini G, J Constantinidis, R Tissot and A Pletscher (1971) Formation of monoamines from various amino acids in the brain after inhibition of extracerebral decarboxylase. Biochem. Pharmacol. 20, 1243-1247.
3. Bertler A, B Falck and E Rosengren (1964) The direct demonstration of a barrier mechanism in the brain capillaries. Acta Pharmacol. Toxicol. (Copenh.) 20, 317-21.
4. Bertler A, B Falck, C Owman and E Rosengren (1966) Localization of monoaminergic blood-brain barrier mechanisms. Pharmacol. Rev. 18, 369-385.
5. 3 -DOPA in various regions of the brain. J. Neurochem. 13, 655-669.
6. 3-norepinephrine in the developing rat. J. Pharmacol. Exp. Ther. 146, 48-53.
7. Hamberger and Masuoka (1965) Localization of catechol-amine uptake in rat brain slices. Acta Pharmacol. Toxicol. (Copenh.) 22, 363-368.
8. Kostrzewa RM (1975) Effects of neonatal 6 hydroxydopa treatment on monamine content of rat brain and peripheral tissues. Res. Commun. Chem. Pathol. Pharmacol. 11, 567- 579.
9. Kostrzewa RM and RE Garey (1976) Effects of 6-hydroxy-dopa on noradrenergic neurons in developing rat brain. J. Pharmacol. Exp. Ther. 197, 105-118.
10. Kostrzewa RM and RE Garey (1977) Sprouting of noradrenergic terminals in rat cerebellum following neonatal treatment with 6-hydroxydopa. Brain Res. 124, 385-391.
11. Kostrzewa RM and JW Harper (1975) Comparison of the neonatal effects of 6-hydroxydopa and 6-hydroxydopamine on growth and development of noradrenergic neurons in the central nervous system, In: Chemical Tools in Catecholamine Research, Vol. I (Jonsson G, T Malmfors and C Sachs, Eds.) (North Holland Publ. Co.:AMsterdam, The Netherlands), pp. 181-188.
12. Liew M-C and R Laverty (1975) Mechanisms of selective depletion of brain regional noradrenaline by systemic 6-hydroxydopamine in newborn rats. Eur. J. Pharmacol. 33, 165-172.
13. Loizou LA (1970) Uptake of monoamines into central neurones and the blood-brain barrier in the infant rat. Br. J. Pharmacol. 40, 800-813.
14. Munson PL, RA Mueller and GR Breese (1995) Principles of Pharmacology (Chapman & Hall:NEw York).
15. Porter CC, JA Totaro and A Burcin (1965) The relationship between radioactivity and norepinephrine concentrations in the brains and hearts of mice following administration of labeled methyldopa or 6-hydroxydopamine. J. Pharmacol. Exp. Ther. 150, 17-22.
16. Sachs C (1973) Development of the blood-brain barrier for 6-hydroxydopamine. J. Neurochem. 20, 1753-1760.
17. Sachs C and G Jonsson (1975) Effects of 6-hydroxydopamine on central noradrenaline neurons during ontogeny. Brain Res. 99, 277-291.
18. Schmidt RH and RK Bhatnagar (1979) Critical periods for noradrenergic regeneration in rat brain regions following neonatal subcutaneous 6-hydroxydopamine. Life Sci. 25, 1641-1650.
19. 3H]norepinephrine by the pituitary gland and various areas of the brain. J. Neurochem. 8, 55-64.
20. Zieher LM and G Jaim-Etcheverry (1979) 6-Hydroxydop-amine during development: Relation between opposite regional changes in brain noradrenaline. Eur. J. Pharmacol. 58, 217-223.